Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Biotech Capital Crunch Meets Clinical Momentum: SPRB, XRTX, BIOA, CGTX, CMND, ANAB & AKTX Signal Funding, Compliance and Pipeline Shifts in 2026

The small-cap biotechnology segment has entered a familiar yet finely balanced phase of the capital cycle. With equity markets selectively open, clinical catalysts regaining prominence, and regulatory compliance shaping near-term trajectories, a cluster of emerging companies is navigating the dual imperatives of funding and …

Nitish Kishor | 21 April 2026

NVIDIA Corporation - From Graphics Chips to the Engine of the AI Era

NVIDIA Corporation stands today as one of the most consequential technology companies in history — not merely because of its market capitalisation, which briefly surpassed $3 trillion in 2024, but because it has engineered the foundational infrastructure on which the artificial intelligence revolution runs. …

Nitish Kishor | 21 April 2026

US futures point higher as ceasefire hopes lift sentiment

The moves come afterWall Streetclosed marginally lower on Monday, when diplomatic friction over Iran negotiations sapped the momentum from a prolonged rally. The S&P 500 slipped 16.92 points, or 0.24 per cent, to 7,109.14 — ending a five-session winning run — while theNasdaqComposite shed …

Team Kalkine | 21 April 2026

Can Artificial Intelligence Do What Central Banks Cannot on Inflation?

The Productivity Argument Gains Institutional Weight

Nitish Kishor | 21 April 2026

US-China Rivalry Enters Critical Phase as Trump-Xi Summit Approaches

Beijing Bound: A Summit Freighted With Consequence

Nitish Kishor | 21 April 2026

Iran War, US Midterm Elections, and Markets: A Politically Amplified Macro Cycle

The Convergence of War and Electoral Arithmetic

Nitish Kishor | 21 April 2026